You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DIPROLENE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Diprolene patents expire, and when can generic versions of Diprolene launch?

Diprolene is a drug marketed by Schering and Organon and is included in four NDAs.

The generic ingredient in DIPROLENE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Diprolene

A generic version of DIPROLENE was approved as betamethasone dipropionate by FOUGERA PHARMS on June 26th, 1984.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DIPROLENE?
  • What are the global sales for DIPROLENE?
  • What is Average Wholesale Price for DIPROLENE?
Summary for DIPROLENE
Drug patent expirations by year for DIPROLENE
Drug Prices for DIPROLENE

See drug prices for DIPROLENE

Recent Clinical Trials for DIPROLENE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cairo UniversityN/A
LEO PharmaPhase 1

See all DIPROLENE clinical trials

Pharmacology for DIPROLENE

US Patents and Regulatory Information for DIPROLENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering DIPROLENE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019408-001 Jan 31, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741-001 Jul 27, 1983 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Schering DIPROLENE betamethasone dipropionate GEL, AUGMENTED;TOPICAL 019408-002 Nov 22, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon DIPROLENE betamethasone dipropionate LOTION, AUGMENTED;TOPICAL 019716-001 Aug 1, 1988 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon DIPROLENE AF betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019555-001 Apr 27, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DIPROLENE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon DIPROLENE betamethasone dipropionate LOTION, AUGMENTED;TOPICAL 019716-001 Aug 1, 1988 ⤷  Sign Up ⤷  Sign Up
Schering DIPROLENE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019408-001 Jan 31, 1986 ⤷  Sign Up ⤷  Sign Up
Schering DIPROLENE betamethasone dipropionate GEL, AUGMENTED;TOPICAL 019408-002 Nov 22, 1991 ⤷  Sign Up ⤷  Sign Up
Schering DIPROLENE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019408-001 Jan 31, 1986 ⤷  Sign Up ⤷  Sign Up
Organon DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741-001 Jul 27, 1983 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.